𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha

✍ Scribed by D. Palmović; I. Kurelac; Jasenka Crnjaković-Palmović

Book ID
105286758
Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
310 KB
Volume
22
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy of hepatitis C: Re-treatment wit
Therapy of hepatitis C: Re-treatment with alpha interferon
✍ A Alberti; L Chemello; F Noventa; L Cavalletto; GianLuca De Salvo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

The long-term benefit of interferon therapy in chronic hepatitis C is limited. During therapy, serum alanine aminotransferase (ALT) levels decrease to normal and hepatitis C virus (HCV) RNA decreases in 40% to 60% of patients. However, most patients relapse after therapy withdrawal, so that no more

Treatment of chronic hepatitis C with ci
Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha
✍ Margarita Pardo; Inmaculada Castillo; Sonia Navas; Dr. Vicente Carreño 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Interferon therapy in cirrhotic patients with hepatitis C virus infection is not efficient. In an at- tempt t o improve the response rate, a pilot study using recombinant human granulocyte colonystimulating factor (rhG-CSF) alone, and in combination with recombinant interferon-alpha (rlFN), was carr